Back to search results

Lymphedema Quality of Life Study: Surgical vs. Non-Surgical Management

This study is looking at how quality of life changes over time for people with lymphedema. Researchers want to compare those who choose to have surgery (specifically, vascularized lymph node transfer) with those who manage their lymphedema without surgery. The study will use surveys like the Upper Limb Lymphedema (ULL-27), Lymphedema Life Impact Scale, and LYMQOL-Leg to understand your experience. You might be able to join if you are 18-80 years old, have primary or secondary lymphedema (ISL Stage 1, 2, or 3) in an arm or leg, and can speak English. The study is currently observational, meaning researchers will watch and collect information, but the recruitment status is unclear.

Study design
This is an observational study with a planned enrollment of 600 participants. It compares two groups: those who have surgery for lymphedema and those who do not.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your quality of life will be measured for up to 40 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03248310

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Recruiting
Not specifiedAges 18–80Observational
Memorial Sloan Kettering Cancer Center
~600 participants
Updated 2025-09-22 on ClinicalTrials.gov
What's tested:Quality of Life Assessments

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Quality of Life
Measured over up to 40 months

Conditions

Lymphedema

Explore related trials

Lymphedema

Where it's being run

3 sites across 1 states
New York3

Study leadership

  • Babak Mahrara, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Babak Mahrara, MD
[email protected]
646-608-8085
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients aged 18-80 years
Primary and secondary lymphedema of the upper or lower extremity
International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema
Proficiency in English language

Exclusion

Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm.
Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.

What this trial measures

  • Quality of Lifeup to 40 months

    Questionnaire to assess quality of life changes